Recap: Venus Concept Q2 Earnings

Shares of Venus Concept VERO rose 15.3% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 102.56% year over year to $0.01, which beat the estimate of ($0.12).

Revenue of $25,828,000 rose by 51.97% year over year, which beat the estimate of $24,260,000.

Looking Ahead

The upcoming fiscal year's revenue expected to be between $102,000,000 and $107,000,000.

How To Listen To The Conference Call

Date: Aug 13, 2021

Time: 08:00 AM

ET Webcast URL: https://78449.themediaframe.com/dataconf/productusers/vero/mediaframe/45834/indexl.html

Technicals

52-week high: $3.44

52-week low: $1.60

Price action over last quarter: Up 22.34%

Company Description

Venus Concept Inc is a medical technology company. It develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic technologies and related practice enhancement services. The company products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Heal, Venus Bliss, ARTAS systems and others. The company provides medical devices and treatments for hair, body, and skin related problems. The company operates domestically as well as internationally. The company generates revenue in the form of Lease and sale of products and services, out of which the majority is generated form the lease received.